Headache in the Emergency Department (ED) - A Multi-Center Research Network to Optimize the ED Treatment of Migraines
Completed
Montefiore Medical Center
Phase 3
2005-07-01
Migraines are a specific type of headache that frequently recur and are very painful.
Although there are many medications that are effective against migraines, none of these
medications cure 100% of migraines. Another problem with migraines is that although many
times they get better after intravenous (IV) treatment in the emergency room (ER), about 1/3
of the time migraines recur the next day. The purpose of this research project is to see if
adding a medication called dexamethasone to standard ER therapy will help patients get better
quicker and stay pain-free more often than if they receive placebo.
Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks
Completed
GlaxoSmithKline
Phase 3
2005-10-01
The purpose of this study is to determine the consistency of response for Treximet (formerly
known as Trexima) when treating four acute migraine attacks at the mild pain phase and within
1 hour of onset of head pain.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
